This trial is active, not recruiting.

Condition indication for laparoscopic surgery (any)
Treatment use of thunderbeat (tm) in laparoscopic surgery
Sponsor Cantonal Hosptal, Baselland
Start date October 2013
End date December 2015
Trial size 250 participants
Trial identifier NCT01999296, Thunderbeat in Laparoscopy


All patients undergoing laparoscopic visceral and gynecologic procedures using the combined bipolar and ultrasonic vessel sealing and dissection device Thunderbeat are entered in a prospective registry. Data will be analysed concerning the safe use of the instrument and perioperative blood loss.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
use of thunderbeat (tm) in laparoscopic surgery

Primary Outcomes

Intra- and postoperative device-related complications
time frame: 30 days
Use of additional vessel sealing devices
time frame: one day

Secondary Outcomes

Perioperative Blood Loss
time frame: 30 days
Duration of Surgery
time frame: one day

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - all patients undergoing laparoscopic visceral or gynecologic surgery - need for a vessel sealing device during surgery Exclusion Criteria: - non able to understand informed consent or missing consent - age <18

Trial information was received from ClinicalTrials.gov and was last updated in July 2015.
Information provided to ClinicalTrials.gov by Cantonal Hosptal, Baselland.